Hopital Hotel-Dieu

Clermont-Ferrand 63058

0 studies enrolling now · 2 studies all time

What they study most

B-Cell Chronic Lymphocytic Leukemia (B-CLL), Cutaneous T-cell Lymphoma (CTCL),

Studies at this site

• Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia — Completed
• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma — Completed